0001209191-20-050147.txt : 20200911 0001209191-20-050147.hdr.sgml : 20200911 20200911162026 ACCESSION NUMBER: 0001209191-20-050147 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200910 FILED AS OF DATE: 20200911 DATE AS OF CHANGE: 20200911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kanfer Jordan CENTRAL INDEX KEY: 0001772350 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38112 FILM NUMBER: 201171152 MAIL ADDRESS: STREET 1: C/O ATHENEX, INC. STREET 2: 1001 MAIN STREET, SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Athenex, Inc. CENTRAL INDEX KEY: 0001300699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 431985966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: 716-898-8625 MAIL ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20131223 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC DATE OF NAME CHANGE: 20040817 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-10 0 0001300699 Athenex, Inc. ATNX 0001772350 Kanfer Jordan C/O ATHENEX, INC. 1001 MAIN STREET, SUITE 600 BUFFALO NY 14203 1 0 0 0 Common Stock 2020-09-10 4 P 0 450 11.49 A 4634 D Stock Option (Right to Buy) 12.06 2029-04-01 Common Stock 10000 10000 D Stock Option (Right to Buy) 11.49 2029-04-03 Common Stock 2500 2500 D Stock Option (Right to Buy) 12.45 2030-06-05 Common Stock 15000 15000 D This option vests in four equal annual installments beginning on April 1, 2020. This option vests in four equal annual installments beginning on April 3, 2020. This option vests in four equal annual installments beginning on June 5, 2021. /s/Teresa Bair, Attorney-in-Fact 2020-09-11